Non-viral, large-scale delivery of gene editing tools for T cell manufacturing
Stefanie Müthel, Andrea Toell
18 September 2025
Register
Managing raw material changes in cell & gene therapy: ensuring compliance and consistency
J King-Hart, M Mendicino, K Kime et al
11 September 2025
Register
Ensuring success in AAV scale-up: key data from case studies across four serotypes
Kelly Cybulski, Kyle Burrell
09 September 2025
Register
Unlock advanced strategies in cell therapy analytics
S Peterson, K Shum, A Chandran et al
04 September 2025
Register
Automating iPSC culture: scalable workflows
Sophia Borate, Nathan Frank
02 September 2025
Register
Achieving high yield and purity in lentiviral production using dPCR and IEX membranes
Jae Hwang, Oxana M Tsygankova
Integrating microbubbles into a CAR-T workflow: more doses in a smaller footprint
Alex Sargent, Crisha Christensen
Commercialization of CAR-T therapy in New Zealand: clinical insights & scalable manufacturing
Tamara Laskowski, Laurence Cooper
Strategic IP landscapes for automated bioreactors in decentralized cell and gene therapy manufacturing: a concise overview
Will Rosellini, Oscar Chow, Oscar Hernandez
Navigating the transition from research to clinical-scale cell therapy manufacture
Johannes Fruehauf, Steven Feldman, Mary Ann Santos
31 July 2025
Innovator Insight
Lessons learned from an end-to-end digitization journey for advanced therapy workflows
Emmanuel Casasola, Joseph Higdon
Point of care manufacture of ATMPs in the UK
Jackie Mulryne, Eleri Abreo
28 July 2025
Expert Insight
Cell therapy clinical translation: ensuring speed to clinic while mitigating risk
Shreya Shukla, Richard Dennett, Steffany Dunn